Series A

With a key drug in trials and a pipeline nearing the clinic, Foghorn Therapeutics brings in a seasoned financial leader to navigate its path to market.

Aventura Private Wealth closes its second Anduril offering, signaling a major shift as private capital floods into high-tech defense disruptors.

With major grants from top foundations, Lario Therapeutics expands its precision neuroscience platform, offering new hope for complex neurological disorders.

With sales connect rates at 3%, TitanX's eight-figure deal for FrontSpin unites AI intelligence with dialer tech to help reps talk to people, not voicemail.

AcuityMD's new Salesforce integration promises to eliminate data silos and boost sales for MedTech firms, marking a strategic leap for the AI unicorn.

With a sales backlog soaring to $7.1M, the clean tech firm is raising capital and realigning leadership to scale its innovative thermal energy systems.

A new platform powered by a 51%-returning AI firm aims to slash fund launch costs by 98%, potentially unleashing a new wave of financial entrepreneurs.

With a new $9.5M facility from SVB, Realta Fusion is accelerating its unique magnetic mirror tech to bring on-site, carbon-free power to heavy industry.

The American Diabetes Association is funding seven visionary scientists using AI, CRISPR, and stem cells to forge the next frontier in diabetes treatment.

With new CEO John Slaven, MineSense aims to scale its ore-sorting tech globally, tackling the urgent need for sustainable critical mineral supplies.

Gaxos.ai secures a deal with ByteDance's BytePlus, gaining access to elite AI video models to challenge giants in the booming creator content market.

Amidst a volatile stock history, GT Biopharma aims to secure vital funding for its innovative NK cell therapy pipeline at a key Toronto conference.

Tech titans like Micron, NVIDIA, and Applied Materials join forces in a $2.5B alliance to forge India into a global deep tech powerhouse.

With its expansion to Europe and LATAM, Halper AI and its founder are betting on a radical idea: the best AI is the one you never have to open.

Iterum Therapeutics secures key Medicare access for its antibiotic ORLYNVAH™, but a costly FDA trial requirement for a new use casts a shadow on its future.

A Taiwanese whisky distributor is betting big on AI with $120M in proposed deals, raising questions of genius, risk, and the frenzy of the AI gold rush.

A new 68-unit affordable senior community in Castle Hayne is secured by a key federal loan, highlighting a successful model for rural housing needs.

With its first dedicated private credit fund, Brigade Capital is targeting a complex, underserved market segment to deliver what larger lenders often miss.

Blue Cross and MassChallenge award five startups $50k each to solve critical health disparities, from endometriosis diagnosis to language access in hospitals.

YBI's new 'Landing Zone' program offers a free, equity-free path for manufacturing startups, leveraging world-class expertise to enter the US market.